Intersect ENT strength attributed to Sinuva appearance on Anthem drug list

Intersect ENT’s (XENT) Sinuva nasal implant appears on Anthem’s (ANTM) national drug list, which is being pointed to as the reason for the stock’s early strength, according to contacts. Intersect ENT shares are up about 5% to $30.08 in early trading.
https://thefly.com/landingPageNews.php?id=2798559